These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 12805482

  • 1. Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester.
    Nakajima T, Takayama T, Miyanishi K, Nobuoka A, Hayashi T, Abe T, Kato J, Sakon K, Naniwa Y, Tanabe H, Niitsu Y.
    J Pharmacol Exp Ther; 2003 Sep; 306(3):861-9. PubMed ID: 12805482
    [Abstract] [Full Text] [Related]

  • 2. Transfection of glutathione S-transferase (GST)-pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide.
    Ban N, Takahashi Y, Takayama T, Kura T, Katahira T, Sakamaki S, Niitsu Y.
    Cancer Res; 1996 Aug 01; 56(15):3577-82. PubMed ID: 8758929
    [Abstract] [Full Text] [Related]

  • 3. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
    Wang W, Liu G, Zheng J.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):61-7. PubMed ID: 17509556
    [Abstract] [Full Text] [Related]

  • 4. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
    Wang YY, Teicher BA, Shea TC, Holden SA, Rosbe KW, al-Achi A, Henner WD.
    Cancer Res; 1989 Nov 15; 49(22):6185-92. PubMed ID: 2804968
    [Abstract] [Full Text] [Related]

  • 5. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
    Geroni C, Marchini S, Cozzi P, Galliera E, Ragg E, Colombo T, Battaglia R, Howard M, D'Incalci M, Broggini M.
    Cancer Res; 2002 Apr 15; 62(8):2332-6. PubMed ID: 11956092
    [Abstract] [Full Text] [Related]

  • 6. Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate.
    Cacciatore I, Caccuri AM, Cocco A, De Maria F, Di Stefano A, Luisi G, Pinnen F, Ricci G, Sozio P, Turella P.
    Amino Acids; 2005 Nov 15; 29(3):255-61. PubMed ID: 16082503
    [Abstract] [Full Text] [Related]

  • 7. Gene therapy of adenovirus mediated CD ::upp/5-FC directed by GSTP1 promoter in cisplatin-resistant ovarian cancer.
    Wang Z, Cai L, Wang H.
    Gynecol Oncol; 2005 Mar 15; 96(3):643-50. PubMed ID: 15721406
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of glutathione-S-transferase as a treatment strategy for multidrug resistance in childhood rhabdomyosarcoma.
    Seitz G, Bonin M, Fuchs J, Poths S, Ruck P, Warmann SW, Armeanu-Ebinger S.
    Int J Oncol; 2010 Feb 15; 36(2):491-500. PubMed ID: 20043085
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and structure-activity relationship of ethacrynic acid analogues on glutathione-s-transferase P1-1 activity inhibition.
    Zhao G, Yu T, Wang R, Wang X, Jing Y.
    Bioorg Med Chem; 2005 Jun 02; 13(12):4056-62. PubMed ID: 15911318
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
    Zhang T, Guan M, Jin HY, Lu Y.
    Gynecol Oncol; 2005 May 02; 97(2):501-7. PubMed ID: 15863151
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
    Tew KD, Monks A, Barone L, Rosser D, Akerman G, Montali JA, Wheatley JB, Schmidt DE.
    Mol Pharmacol; 1996 Jul 02; 50(1):149-59. PubMed ID: 8700107
    [Abstract] [Full Text] [Related]

  • 16. Cellular response to a glutathione S-transferase P1-1 activated prodrug.
    Rosario LA, O'Brien ML, Henderson CJ, Wolf CR, Tew KD.
    Mol Pharmacol; 2000 Jul 02; 58(1):167-74. PubMed ID: 10860939
    [Abstract] [Full Text] [Related]

  • 17. Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system.
    Kolfschoten GM, Pinedo HM, Scheffer PG, Schlüper HM, Erkelens CA, Boven E.
    Gynecol Oncol; 2000 Mar 02; 76(3):362-8. PubMed ID: 10684711
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.